Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.37 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.36 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.36 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.36 |
| ▸ | CETP | P11597 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TYR | P14679 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | STAT3 | P40763 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trehalose SCHEMBL3727947 | 1.00 | PTPN1 (0.41) | PTPN1L3MBTL1MEN1KMT2ASYNJ2 | |
| Trehalose SCHEMBL8413279 | 1.00 | PTPN1 (0.41) | PTPN1L3MBTL1MEN1KMT2ASYNJ2 | |
| Trehalose SCHEMBL10381940 | 0.99 | PTPN1 (0.40) | PTPN1L3MBTL1MEN1KMT2ASYNJ2 | |
| Trehalose SCHEMBL8345963 | 0.91 | LGALS8 (0.43) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Demannose SCHEMBL2637762 | 0.90 | MEN1 (0.40) | PTPN1L3MBTL1MEN1KMT2ALGALS8 | |
| Maltitol SCHEMBL15271873 | 0.90 | L3MBTL1 (0.36) | PTPN1L3MBTL1MEN1KMT2ASYNJ2 | |
| Cellobiose SCHEMBL23699869 | 0.89 | LGALS8 (0.44) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Demannose SCHEMBL8488325 | 0.89 | LGALS8 (0.44) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Cellobiose SCHEMBL17941750 | 0.89 | LGALS8 (0.44) | MEN1KMT2ALGALS8LGALS3LGALS4 | |
| Maltose SCHEMBL537670 | 0.89 | LGALS8 (0.44) | MEN1KMT2ALGALS8LGALS3LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4221778-A1 | MATRICES FOR SELECTIVE BINDING OF AT LEAST ONE COMPONENT FROM A BODY FLUID | Alteco Medical AB (SE) | 2023-08-09 | — | — | EP | claimed |
| CN-103450288-B | A kind of isolation and purification method of trehalose | QILU UNIVERSITY OF TECHNOLOGY (CN) | 2016-05-11 | — | — | CN | claimed |
| CN-103450288-A | Separation and purification method of trehalose | UNIV QILU TECHNOLOGY | 2013-12-18 | — | — | CN | claimed |
| EP-0160743-B1 | MINIATURIZED YEAST IDENTIFICATION SYSTEM | Wadley Technologies, Inc. (US) | 1989-03-22 | — | — | EP | claimed |
| US-20210299093-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR PULMONARY HYPERTENSION COMPRISING UNSATURATED 5-MEMBERED HETEROCYCLE-CONTAINING COMPOUND | TOHOKU UNIVERSITY (JP) | 2021-09-30 | — | — | US | disclosed |
| CN-112839524-A | Insect feed | 嘉吉公司 | 2021-05-25 | — | — | CN | disclosed |
| CN-110506111-A | Trehalose phosphorylase | C LECTA GMBH | 2019-11-26 | — | — | CN | disclosed |
| CN-108779501-A | powder containing α, α -trehalose dihydrate crystal, method for producing same, and use thereof | 株式会社林原 | 2018-11-09 | — | — | CN | disclosed |
| CN-105418694-B | A kind of preparation method of trehalose | 廊坊梅花生物技术开发有限公司 | 2018-07-17 | — | — | CN | disclosed |
| CN-103450288-B | A kind of isolation and purification method of trehalose | QILU UNIVERSITY OF TECHNOLOGY (CN) | 2016-05-11 | — | — | CN | disclosed |
| CN-103450288-B | A kind of isolation and purification method of trehalose | QILU UNIVERSITY OF TECHNOLOGY (CN) | 2016-05-11 | — | — | CN | disclosed |
| CN-105418694-A | Preparation method of trehalose | LANGFANG MEIHUA BIO-TECHNOLOGY DEV CO LTD | 2016-03-23 | — | — | CN | disclosed |
| US-5716838-A | CULTURE OF MICROORGANISMS SUCH AS RHIZOBIUM, ARTHROBACTER | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1998-02-10 | — | — | US | disclosed |
| WO-1997042980-A1 | METHODS OF TERMINAL STERILIZATION OF BIOLOGICAL PRODUCTS | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1997-11-20 | — | — | WO | disclosed |
| US-5681826-A | INCLUDES A SUGAR ALCOHOL AND A NON-REDUCING SACCHARIDE CONTAINING TREHALOSE | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1997-10-28 | — | — | US | disclosed |
| US-5677442-A | CRYSTALLIZING FROM CONCENTRATED AQUEOUS SOLUTION | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1997-10-14 | — | — | US | disclosed |
| US-5610047-A | TREHALOSE | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1997-03-11 | — | — | US | disclosed |
| US-5455168-A | Production of non-reducing saccharides | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1995-10-03 | — | — | US | disclosed |
| CN-1105067-A | Non-reducing saccharide-forming enzyme, preparation and use thereof | HAYASHIBARA BIOCHEM LAB (JP) | 1995-07-12 | — | — | CN | disclosed |
| CN-1091470-A | Unreductases produced of saccharide and preparation thereof and application | HAYASHIHARA BIOCHEMICAL INST C (JP) | 1994-08-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210299093-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR PULMONARY HYPERTENSION COMPRISING UNSATURATED 5-MEMBERED HETEROCYCLE-CONTAINING COMPOUND | PTGIR, AGTR1, SHROOM3 | PTPN1 4126/4885L3MBTL1 2992/4885MEN1 1704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.